Pregled bibliografske jedinice broj: 921371
Therapy for bisphosphonate-related osteonecrosis of the jaw: a systematic review
Therapy for bisphosphonate-related osteonecrosis of the jaw: a systematic review // Revista Portuguesa de Estomatologia, Medicina Dentária e Cirurgia Maxilofacial, 58 (2017), 3; 133-138 doi:10.24873/j.rpemd.2017.10.022 (međunarodna recenzija, pregledni rad, znanstveni)
CROSBI ID: 921371 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Therapy for bisphosphonate-related osteonecrosis of the jaw: a systematic review
Autori
Francischettia, Felipe Lara ; Ferraz Júnior, Antônio Márcio Lima ; Guerra de Oliveira, Rodrigo ; Badel, Tomislav ; Morrison, Archie ; Gomes, Raquel Zita
Izvornik
Revista Portuguesa de Estomatologia, Medicina Dentária e Cirurgia Maxilofacial (1646-2890) 58
(2017), 3;
133-138
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
bisphosphonates ; bisphosphonates related osteonecrosis of the Jaw (BRONJ) ; bisphosphonates therapy ; cancer and osteoporosis treatment
Sažetak
Bisphosphonates are usually prescribed for treating metabolic and neoplastic bone disorders. Intravenous bisphosphonate formulations containing nitrogen are the ones most often associated with osteonecrosis of the jaw. The available therapies range from conservative procedures to invasive procedures. The literature was systematically reviewed to determine the therapies available and their efficacy. Related studies published originally in any language from January 2003 to April 2017 and indexed in the MEDLINE (National Library of Medicine) and Cochrane databases were analyzed. The following phrases were searched: “Bisphosphonate-Associated Osteonecrosis of the Jaw” OR “Bisphosphonate Osteonecroses” OR “Bisphosphonate Osteonecrosis” OR “Bisphosphonate- Induced Osteonecrosis of the Jaw” OR “Bisphosphonate-Related Osteonecrosis of the Jaw” AND “treatment” OR “therapy” OR “therapeutics” OR “treatment outcome.” The inclusion criteria were randomized controlled clinical trials, pertinent retrospective studies, systematic reviews, and meta-analyses. The levels of evidence of the studies were assessed independently by two referees, experts in the area. This review confirms that the therapeutic approaches are based only on expert recommendations and opinions. Hence, preventive guidelines are mandatory because there is no gold standard in the therapy of bisphosphonate-related osteonecrosis of the jaw.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti, Dentalna medicina
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Emerging Sources Citation Index (ESCI)
- Scopus